Neurotransmitter synthesis and behavioural adaptation Amino acids are precursors to key neurotransmitters
First insulinization with basal insulin in patients with type 2 diabetes in a real-world setting in Asia
While mTORC2 primarily promotes cell proliferation and survival through the phosphorylation of AKT, many tumors need mTORC1 to maintain their ability to control protein synthesis and cell growth, as well as to coordinate nutrient and energy supply to ensure that they undergo unrestricted cell division (103)
However, these mainstream therapies face critical limitations including the rapid emergence of drug resistance, FKS1/FKS2 gene mutations reducing -1,3-glucan synthase affinity, Targeted enzyme (Erg11p) modification, overexpression of efflux pumps (CDR1, MDR1), and upregulation of the ergosterol pathway mediate azole resistance (Pristov and Ghannoum, 2019)
Put another way, only 1 in 7 patients in the study remained on therapy at the end of two years
Semax upregulates BDNF production and modulates neurotransmitter balance